Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Capital/Financing Update 2023

Mar 8, 2023

65285_rns_2023-03-08_48f02170-1905-4b57-b431-9548b4ccac4b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

09 March 2023

ADVENTIST’S FINAL DEPLOYMENT PHASE BEGINS

  • Existing customer, Adventist Health System, orders Mach7 PACS[1] for remaining 15 contracted hospitals

  • Latest hospital orders have Total Contract Value (TCV) of A$7.1 million[2]

  • Capital contract expected to contribute A$3.0 million to revenue in FY23

Mach7 Technologies Limited (“Mach7” or the “Company”) (ASX:M7T), a company specialising in innovative medical imaging software solutions, is pleased to announce that existing customer, Adventist Health System/West (“Adventist Health”), has signed sales orders for the remaining 15 contracted hospitals that are yet to deploy Mach7’s PACS.

A contract regarding Adventist Health’s PACS replacement program for its 22 hospitals was announced in January 2021. The initial, overarching agreement was valued at over A$7.9 million and included A$2.4 million of sales orders for the first seven hospitals. The remaining order forms for 15 hospitals have now been received and have a value of A$7.1 million including scope expansion.

The Adventist Health PACS solution involves the Mach7 Enterprise Imaging Platform, eUnity Diagnostic Viewer, Mach7 Universal Worklist, Mach7 QC Module and Mach7 Clinical Portal. The capital contract covering the 15 Adventist Health hospitals is expected to contribute A$3.0 million to revenue in FY23.

Headquartered in Roseville, California, Adventist Health is a faith-based, non-profit integrated health system serving more than 80 communities on the West Coast of the United States and in Hawaii. Founded on Seventh-day Adventist heritage and values, Adventist Health provides care in hospitals as well as in clinics, home care agencies, hospice agencies and joint-venture retirement centers in both rural and urban communities.

Mach7’s Chief Executive Officer, Mike Lampron said: “ We have developed a strong and collaborative partnership with Adventist Health over the last few years and we are delighted that its enterprise imaging growth strategy will soon be fully realised. Our implementation and support teams have delivered high quality outcomes for the hospitals in the initial deployment phase, and this positive experience has helped accelerate the rollout program to cover the entire Adventist hospital network.”

Released on authority of the Board by:

Mike Lampron

Managing Director and Chief Executive Officer

1 Picture Archive Communication System

2 Exchange rate: AUD/USD = $0.675; All values expressed in Australian dollars unless otherwise stated

For more information, contact:

Rebecca Thompson Head of Investor Relations Mach7 Technologies Limited +61 (0) 416 079 329 [email protected]

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organisations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Diagnostic Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Diagnostic Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

==> picture [150 x 54] intentionally omitted <==

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com